H9 subtype avian influenza virus isolate and vaccine composition prepared thereby

A technology of avian influenza virus and vaccine composition, which is applied in the field of poultry biopharmaceuticals, can solve the problems such as the decline of immune protection efficacy of vaccine strains, and achieve the effects of significant cross-immunogen characteristics, good application prospects, and good immune efficacy

Active Publication Date: 2014-05-14
PU LIKE BIO ENG +1
View PDF3 Cites 28 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The main reason for this phenomenon is that there is a large genetic distance and antigenic difference between the vaccine strain and the currently circulating wild strain, resulting in a decline in the immune protection efficacy of the vaccine strain.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • H9 subtype avian influenza virus isolate and vaccine composition prepared thereby
  • H9 subtype avian influenza virus isolate and vaccine composition prepared thereby
  • H9 subtype avian influenza virus isolate and vaccine composition prepared thereby

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0026] Example 1: Isolation and identification of virus strains

[0027] In 2008, throat and cloacal swabs were collected from broiler chickens in Zhucheng, Shandong, placed in virus preservation solution (10,000 U of penicillin and 2,000 μg of streptomycin per ml, pH: 7.0), and frozen at -20°C. After the swab samples were processed, they were inoculated with 10-day-old SPF chicken embryos (Beijing Meria Weitong Experimental Animal Co., Ltd.). The harvested chicken embryo fluid samples were tested for hemagglutination with 1% chicken red blood cell suspension, the positive samples were prepared with 4 units of antigen, and then the 4 positive sera of H9 AIV, H5 AIV, EDS and ND passed the hemagglutination inhibition (HI) test After serological identification, it was confirmed as H9 subtype AIV. Take the virus liquid and use the virus RNA extraction kit to extract RNA, and reverse transcribe the cDNA. The reverse transcription primer sequence is: 5'-AGCAAAAGCAGG-3'. PCR amplif...

example 2

[0040] Example 2: Vaccine Composition Preparation

[0041] 1. Preparation of virus fluid

[0042] Get H9 subtype avian influenza virus SZ strain (CCTCC V201240) virus seeds, dilute to 10 with sterile normal saline -3 (Take 0.1ml of the virus liquid and add it to 0.9ml of sterile saline, shake and mix, and then dilute twice accordingly), and inoculate 10-day-old susceptible chicken embryos through the allantoic cavity (purchased from Beijing Merial Verton Experimental Co., Ltd. SPF eggs from Animal Technology Co., Ltd. self-hatch), 0.1ml per embryo (including 10 5 EID 50 ). Seal the pinhole after inoculation, and continue to incubate at 36-37°C without turning the eggs. After 96 hours, take it out, put the air chamber upright, and cool it at 2-8°C for 12-24 hours. Harvest the embryonic liquid from the cooled chicken embryos. The harvested virus liquid sampling, according to the method in appendix 7 of " Veterinary Pharmacopoeia of the People's Republic of China " (2010 ed...

example 3

[0065] Example 3: Strain Cross Immunogenicity

[0066] For researching the cross-protection of H9 subtype avian influenza virus SZ strain (CCTCC V201240) to other strains, according to the preparation method of vaccine in example 2, prepared avian influenza (H9 subtype) inactivated vaccine (HL strain) respectively ( HL strain inactivated vaccine for short), avian influenza (H9 subtype) inactivated vaccine (SZ strain) (referred to as SZ strain inactivated vaccine), and containing two antigens of HL and SZ (antigen ratio is 1:1, V / The inactivated vaccine of V) (being called for short HL+SZ strain inactivated vaccine), immunizes SPF chicken (purchased from Beijing Meria Weitong Experimental Animal Technology Co., Ltd.) respectively, chooses HL strain and SZ strain to attack respectively 3 weeks after immunization, and Perform virus isolation. The results showed that the virus shedding rates of the HL strain inactivated vaccine immunization group were 0 / 10 and 4 / 10 respectively,...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an avian influenza virus isolate belonging to an H9 subtype. An amino acid sequence of an HA1 structural domain of hemagglutinin has the following characteristic sites: 69-bit P, 180-bit A, 221-bit N and 236-bit R; the vaccine composition prepared by the H9 subtype avian influenza virus isolate with the following characteristic sites has good immune efficiency, and is superior to the vaccine prepared by the strain in the prior art in effect, cross protection can be provided for a popular wild strain, significant cross immunogen features are displayed, and the avian influenza virus isolate has a good application prospect in the aspect of preventing and treating poultry cross immune protection.

Description

technical field [0001] The invention belongs to the technical field of poultry biopharmaceuticals, and relates to an isolated strain of H9 subtype avian influenza virus and a vaccine composition prepared therefrom. Background technique [0002] Avian influenza (AI) is an infection and / or disease syndrome in birds caused by influenza A viruses. According to the pathogenicity of the pathogen, it can be divided into two types: high pathogenicity and low pathogenicity. Among the low pathogenicity avian influenza viruses, the H9 subtype is the most widely distributed and the most harmful. H9 subtype avian influenza virus (H9 AIV) single pathogenic infection often does not cause clinical symptoms, but because it is easy to synergize with other pathogens, it causes secondary infection, which causes complex respiratory diseases and even death in broilers and laying hens, poultry Decreased egg production and immunosuppression, etc., can cause significant losses to the poultry indus...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12N7/00A61K39/145A61P31/16C12R1/93
Inventor 张许科孙进忠白朝勇
Owner PU LIKE BIO ENG
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap